￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Tucatinib/tucatinib side effects and countermeasures

2026-02-01 22:25:32

Check Details
Alpelisib-Piqray latest quotation inquiry channels and methods

2026-02-01 22:25:32

Check Details
FDA approves selumetinib/coselumab for symptomatic NF-1-associated inoperable plexiform neurofibromas in children

2026-02-01 22:25:32

Check Details
Casdatifan/cabotinib is effective in pretreated ccRCC

2026-02-01 22:25:32

Check Details
Identification of biomarkers of lorlatinib/lorlatinib treatment resistance in patients with ALK-positive advanced non-small cell lung cancer

2026-02-01 22:25:32

Check Details
The specific price situation of Bosutinib

2026-02-01 22:25:32

Check Details
Will the disease develop crazily after discontinuing Upatinib/Refu?

2026-02-01 22:25:32

Check Details
What diseases can Nintedanib/Vigat mainly treat and who is it suitable for?

2026-02-01 22:25:32

Check Details
What are the specific effects of bimetinib/bemetinib?

2026-02-01 22:25:32

Check Details
Will Teclistamab-cqyv be included in medical insurance in 2025?

2026-02-01 22:25:32

Check Details
Analyze the drug differences between Quizartinib and Giritinib

2026-02-01 22:25:32

Check Details
What is the latest market price of a box of Selumetinib?

2026-02-01 22:25:32

Check Details
Category
相关知识